Ketamine Therapy in Ohio

Ketamine therapy in Ohio is governed by a combination of federal regulations and state-level oversight administered by the State Medical Board of Ohio and the Ohio State Board of Pharmacy. Ketamine is classified as a Schedule III controlled substance under the federal Controlled Substances Act, meaning that any clinic or provider administering ketamine must maintain a valid DEA registration and adhere to strict prescribing, dispensing, and record-keeping requirements. Ohio providers must also comply with state pharmacy laws governing the acquisition, storage, and dispensing of controlled substances, ensuring that ketamine is handled within a secure and regulated clinical environment.

Physicians and other licensed practitioners administering ketamine in Ohio must hold an active, unrestricted Ohio medical license and operate within the scope of their training and specialty. While Ohio does not have ketamine-specific statutes, the State Medical Board of Ohio enforces general standards of care that apply to all controlled substance treatments, including requirements around patient evaluation, informed consent, and medical documentation. Clinics offering ketamine-assisted psychotherapy or esketamine (Spravato) services face additional requirements, as Spravato is an FDA-approved medication with a mandatory Risk Evaluation and Mitigation Strategy (REMS) program that requires in-office administration and post-dose patient monitoring.

Patients seeking ketamine therapy in Ohio should be aware of the following key regulatory considerations:

• Treatment must be administered or directly supervised by a licensed medical professional
• A thorough medical and psychiatric evaluation is typically required before treatment begins
• Clinics must maintain DEA registration and comply with Ohio controlled substance reporting requirements
• Ketamine infusions for off-label uses, such as depression or chronic pain, are not covered by most insurance plans and are provided on a private-pay basis
• Telehealth prescribing of ketamine is subject to evolving federal and state regulations, particularly following guidance updates from the DEA

The regulatory landscape surrounding ketamine therapy continues to evolve at both the state and federal levels. Ohio practitioners and clinics are expected to stay current with guidance from the State Medical Board of Ohio, the DEA, and the FDA as policies around controlled substance prescribing and emerging mental health treatments develop. Patients are encouraged to verify that any clinic they consider is operating in full compliance with applicable licensure and regulatory standards before beginning treatment.